Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: Systematic review with meta-analyses and trial sequential analyses of randomised trials

European Journal of Clinical Pharmacology

Volumn 66, Issue 12, 2010, Pages 1177-1187

  Penninga, Luit ^a   Møller, Christian H ^a   Gustafsson, Finn ^a   Steinbrüchel, Daniel A ^a   Gluud, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Calcineurin inhibitors; Cyclosporine; Heart transplantation; Meta analysis; Tacrolimus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PLACEBO; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

BASAL CELL CARCINOMA; BIBLIOGRAPHIC DATABASE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; GINGIVA HYPERPLASIA; GRAFT INFECTION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; META ANALYSIS; MICROEMULSION; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CYCLOSPORINE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TACROLIMUS;

EID: 78649320359     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0902-6     Document Type: Review

References (48)

1. DO Taylor J Stehlik LB Edwards, et al. 2009 Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009 J Heart Lung Transplant 28 1007 1022 10.1016/j.healun. 2009.08.014 19782283
2. H Valantine 2000 Neoral use in the cardiac transplant recipient Transplant Proc 32 27S 44S 1:CAS:528:DC%2BD3cXjt1eiu7k%3D 10.1016/S0041-1345(00) 00862-9 10814748
3. MH Kapturczak HU Meier-Kriesche B Kaplan 2004 Pharmacology of calcineurin antagonists Transplant Proc 36 25S 32S 1:CAS:528:DC%2BD2cXisVelsrg%3D 10.1016/j.transproceed.2004.01.018 15041303 (Pubitemid 38373828)
4. TE Starzl S Todo J Fung AJ Demetris R Venkataramman A Jain 1989 FK 506 for liver, kidney, and pancreas transplantation Lancet 2 1000 1004 1:STN:280:DyaK3c%2Fkt1Ojsg%3D%3D 10.1016/S0140-6736(89)91014-3 2478846
5. PL McCormack GM Keating 2006 Tacrolimus: in heart transplant recipients Drugs 66 2269 2279 1:CAS:528:DC%2BD2sXhtVCmu70%3D 10.2165/00003495-200666170- 00010 17137409 (Pubitemid 44878534)
6. NR Banner 2006 Tacrolimus: in heart transplant recipients-a viewpoint by Nicholas R. Banner Drugs 66 2280 2282 10.2165/00003495-200666170-00012
7. Higgins JP, Green S (2009) Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated September 2009). The Cochrane Collaboration. Available from www.cochrane-handbook.org
8. D Moher A Liberati J Tetzlaff DG Altman 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement J Clin Epidemiol 62 1006 1012 10.1016/j.jclinepi.2009.06.005 19631508
9. S Stewart GL Winters MC Fishbein, et al. 2005 Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 1710 1720 10.1016/j.healun.2005.03. 019 16297770 (Pubitemid 41641841)
10. P Royle N Waugh 2003 Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system Health Technol Assess 7 iii ix-51
11. KF Schulz I Chalmers RJ Hayes DG Altman 1995 Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 408 412 1:STN:280:DyaK2M7itlOitA%3D%3D 10.1001/jama.273.5.408 7823387
12. JP Higgins SG Thompson 2002 Quantifying heterogeneity in a meta-analysis Stat Med 21 1539 1558 10.1002/sim.1186 12111919 (Pubitemid 34746062)
13. DG Altman JM Bland 2003 Interaction revisited: the difference between two estimates BMJ 326 219 10.1136/bmj.326.7382.219 12543843
14. J Wetterslev K Thorlund J Brok C Gluud 2008 Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis J Clin Epidemiol 61 64 75 10.1016/j.jclinepi.2007.03.013 18083463 (Pubitemid 350245732)
15. M Grimm M Rinaldi NA Yonan, et al. 2006 Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large European trial Am J Transplant 6 1387 1397 1:CAS:528:DC%2BD28XlvVyhtb8%3D 10.1111/j.1600-6143.2006.01300.x 16686762 (Pubitemid 44030321)
16. J Kobashigawa J Patel H Furukawa, et al. 2006 Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients J Heart Lung Transplant 25 434 439 10.1016/j.healun.2005.11.452 16563974
17. Kobashigawa JA, Miller LW, Russell SD (2004) A randomized, prospective, multicenter comparison of tacrolimus, mycopholate mofetil (mmf) and steroids vs cyclosporine microemulsion, mmf and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplantation recipients-6 month report. 3rd International Congress on Immunosuppression, San Diego
18. Kobashigawa JA, Patel JK, Furukawa H, Marquez A, Oeser BT, Laks H (2004) Five-year results of a randomized single center study of tacrolimus versus microemulsion cyclosporine in heart transplant patients. 3rd International Congress on Immunosuppression, San Diego
19. JA Kobashigawa LW Miller SD Russell, et al. 2006 Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 6 1377 1386 1:CAS:528:DC%2BD28XlvVyhtb4%3D 10.1111/j.1600-6143.2006.01290.x 16686761 (Pubitemid 44030320)
20. BM Meiser J Groetzner I Kaczmarek, et al. 2004 Tacrolimus or cyclosporine: which is the better partner for mycophenolate-mofetil in heart transplant recipients? Transplantation 78 591 598 1:CAS:528:DC%2BD2cXntVCqs7s%3D 10.1097/01.TP.0000129814.52456.25 15446320 (Pubitemid 39097107)
21. BM Meiser T Scheersoi M Pfeiffer, et al. 2000 Comparison of trough level adjusted MMF application in combination with either cyclosporine or tacrolimus in a randomized study after heart transplantation Transplantation 69 695
22. BM Meiser P Uberfuhr A Fuchs, et al. 1996 Comparison between tacrolimus (FK506) and cyclosporin A (CyA) after heart transplantation: a randomised, controlled clinical study Zeitschr Kardiol 85 Suppl 2 133
23. BM Meiser P Uberfuhr A Fuchs, et al. 1998 Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection J Heart Lung Transplant 17 782 788 1:STN:280: DyaK1czpvVWqtw%3D%3D 9730427
24. B Reichart B Meiser M Vigano, et al. 1998 European multicenter tacrolimus (FK506) heart pilot study: one-year results-European tacrolimus multicenter heart study group J Heart Lung Transplant 17 1998
25. SMD Pollock-BarZiv AI Dipchand BW McCrindle N Nalli LJ West 2008 Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up J Heart Lung Transplant 24 190 194 10.1016/j.healun.2004.11.006
26. M Rinaldi C Pellegrini L Martinelli, et al. 1997 FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study J Heart Lung Transplant 16 1001 1010 1:STN:280:DyaK1c%2FislWgtg%3D%3D 9361242
27. DO Taylor ML Barr B Radovancevic, et al. 1999 A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 336 345 1:STN:280:DyaK1M3ktlCrtw%3D%3D 10.1016/S1053-2498(98)00060-6 10226898 (Pubitemid 29205269)
28. CH Wang WJ Ko N Chou SS Wang 2004 Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan Transplant Proc 36 2384 2385 1:CAS:528: DC%2BD2cXhtVWjsb%2FP 10.1016/j.transproceed.2004.08.059 15561256 (Pubitemid 39550851)
29. CH Wang WJ Ko N Chou SS Wang 2004 Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral Transplant Proc 36 2386 2387 1:CAS:528:DC%2BD2cXhtVWjsb%2FI 10.1016/j.transproceed.2004.08.053 15561257 (Pubitemid 39550852)
30. SS Wang NK Chou NH Chi, et al. 2008 Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus Transplant Proc 40 2607 2608 1:CAS:528:DC%2BD1cXht1eitrvP 10.1016/j. transproceed.2008.08.072 18929814
31. J Groetzner BM Meiser J Schirmer, et al. 2001 Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? Transplant Proc 33 1461 1464 10.1016/S0041-1345(01)01906-6 11267373 (Pubitemid 32237926)
32. J Groetzner B Meiser J Schirmer, et al. 2001 Tacrolimus/mycophenolate mofetil vs cyclosporine/mycophenolate mofetil: comparison of mycophenolate mofetil acid trough levels and coronary vasomotor function J Heart Lung Transplant 20 191 10.1016/S1053-2498(00)00398-3
33. J Groetzner B Meiser J Schirmer, et al. 2002 Tacrolimus/mycophenolate mofetil vs cyclosporine/mycophenolate mofetil: impact on infections following cardiac transplantation J Heart Lung Transplant 21 120 10.1016/S1053-2498(01) 00615-5
34. J Schirmer B Meiser A Kadner, et al. 2001 Tacrolimus versus cyclosporine after HTX: comparison of long-term effects J Heart Lung Transplant 20 191 10.1016/S1053-2498(00)00399-5
35. M Grimm M Rinaldi NA Yonan 2003 Tacrolimus versus cyclosporine after HTX: comparison of long-term effects J Heart Lung Transplant 22 S92 10.1016/S1053-2498(02)00732-5
36. DO Taylor ML Barr B Radovancevic, et al. 1997 A comparison of tacrolimus- and cyclosporine-based immunosuppression in cardiac transplantation J Heart Lung Transplant 16 72
37. P Petrakopoulou L Anthopoulou M Muscholl, et al. 2006 Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression J Am Coll Cardiol 47 1622 1629 1:CAS:528:DC%2BD28XltlCisrk%3D 10.1016/j.jacc.2005.10.073 16631000
38. N von Steinbüchel H Limm C Leopold D Carr 2000 Assessment of health-related quality-of-life in patients after heart transplantation under therapy with tacrolimus or cyclosporine Transpl Int 13 Suppl 1 S609 S614 11112084
39. B Reichart B Meiser M Vigano, et al. 2001 European multicenter tacrolimus heart pilot study: three year follow-up J Heart Lung Transplant 20 249 250 10.1016/S1053-2498(00)00567-2 11250493
40. LL Gluud 2006 Bias in clinical intervention research Am J Epidemiol 163 493 501 10.1093/aje/kwj069 16443796
41. HJ Eisen RE Hobbs SF Davis, et al. 2001 Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine-results at 24 months after transplantation Transplantation 71 70 78 1:CAS:528:DC%2BD3MXhtVart78%3D 10.1097/00007890-200101150-00012 11211198
42. BK Podesser M Rinaldi NA Yona, et al. 2005 Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study Transplantation 79 65 71 1:CAS:528: DC%2BD2MXhs1eis7o%3D 10.1097/01.TP.0000140965.83682.D6 15714171 (Pubitemid 40140002)
43. M Cantarovich J Barkun N Giannetti R Cecere JG Besner J Tchervenkov 2004 History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion Transplant Proc 36 442S 447S 1:CAS:528: DC%2BD2cXisVeluro%3D 10.1016/j.transproceed.2004.01.004 15041383 (Pubitemid 38373907)
44. M Iversen F Nilsson J Sipponen, et al. 2009 Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study J Heart Lung Transplant 28 919 926 10.1016/j.healun.2009.05.022 19716045
45. Y Fan YB Xiao YG Weng R Hetzer 2009 Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis J Heart Lung Transplant 28 58 66 10.1016/j.healun.2008.10.004
46. MR Mehra PA Uber MH Park AK Prasad RL Scott 2001 A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients Transplant Proc 33 1606 1607 1:CAS:528: DC%2BD3MXitV2msLg%3D 10.1016/S0041-1345(00)02611-7 11267438 (Pubitemid 32237991)
47. VC McAlister E Haddad E Renouf RA Malthaner MS Kjaer LL Gluud 2006 Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis Am J Transplant 6 1578 1585 1:CAS:528:DC%2BD28XnsFGgsbY%3D 10.1111/j.1600-6143.2006.01360.x 16827858 (Pubitemid 43945797)
48. AC Webster RC Woodroffe RS Taylor JR Chapman JC Craig 2005 Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data BMJ 331 810 821 1:CAS:528:DC%2BD2MXhtFyhu7nM 10.1136/bmj.38569.471007.AE 16157605 (Pubitemid 41442360)